Abstract

Aim: The case report aims to highlight the unusual presentation of Malignant Melanoma. Malignant melanoma is a tumour of melanocytic origin. Lymphatic and haematogenous spread is common in this condition. Objectives: To establish the importance of Immunohistochemistry in order to treat Malignant Melanoma. Material and Method: We present a case of 51 year old male with a lump in left chest region. Imaging done shows a lesion in the right lower lobe of lung and a right suprarenal mass. Histopathology of the lesion in conjunction with immunohistochemical markers FLI1, S 100, HMB 45, Melan confirm the diagnosis of malignant melanoma. Result: Due to its rare presentation and in some cases unusual presentation Malignant Melanoma is often difficult to diagnose or diagnosed late, thereby making it potentially life threatening.In our case report the immunohistochemical examination was done which helped us to establish a solid diagnosis of unusual presentation of Malignant Melanoma, so that the most appropriate therapeutic management can be applied favouring a better clinical outcome. Conclusion: Clinically Malignant Melanoma do not present with distinctive features, therefore there diagnosis can be established with the help of histopathology with specific tissue markers.

• 1.   Magro CM, Crowson AN, Mihm Jr MC. Unusual variants of malignant melanoma. Modern pathology. 2006 Jan 1;19:S41-70.
• 2.   Salerni G, Terán T, Puig S, Malvehy J, Zalaudek I, Argenziano G, Kittler H. Meta‐analysis of digital dermoscopy follow‐up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. Journal of the European Academy of Dermatology and Venereology. 2013 Jul;27(7):805- 14.
• 3.   Liang KV, Sanderson SO, Nowakowski GS, Arora AS. Metastatic malignant melanoma of the gastrointestinal tract Mayo Clin Proc. 2006;81:511–6
• 4.   Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Current opinion in oncology. 2000 Mar 1;12(2):181-5.
• 5.   Vijuk G, Coates AS. Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study. Annals of oncology. 1998 Apr 1;9(4):419-22.
• 6.   Kamposioras K, Pentheroudakis G, Pectasides D, Pavlidis N. Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Critical reviews in oncology/hematology. 2011 May 1;78(2):112-26.
• 7.   Saleh FH, Crotty KA, Hersey P, Menzies SW. Primary melanoma tumour regression associated with an immune response to the tumour‐associated antigen melan‐A/MART‐1. International journal of cancer. 2001 Nov 15;94(4):551-7.
• 8.   Gupta TD, BRASFIELD RD. Metastatic melanoma of the gastrointestinal tract. Archives of Surgery. 1964 Jun 1;88(6):969-73.
• 9.   Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. Journal of the American College of Surgeons. 1995 Sep 1;181(3):193-201.
• 10.   Wysocki WM, Komorowski AL, Darasz Z. Gastrointestinal metastases from malignant melanoma: report of a case. Surgery today. 2004 Jun;34(6):542-6.

Data Sharing Statement

Funding